Tiziana Life Sciences PLC (TILS) Rating Reiterated by Beaufort Securities

Beaufort Securities reissued their speculative buy rating on shares of Tiziana Life Sciences PLC (LON:TILS) in a research report report published on Wednesday.

Shares of Tiziana Life Sciences PLC (LON:TILS) opened at 201.50 on Wednesday. The company’s 50-day moving average price is GBX 184.44 and its 200 day moving average price is GBX 192.33. Tiziana Life Sciences PLC has a one year low of GBX 91.35 and a one year high of GBX 224.81. The stock’s market capitalization is GBX 186.96 million.

var userip;Your IP Address: document.write(userip);

About Tiziana Life Sciences PLC

Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers. Its products in clinical stage include Milciclib and Foralumab. Its products in pre-clinical stage include TZLS-101 and TZLS-214.

Receive News & Ratings for Tiziana Life Sciences PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences PLC and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.